ClinicalTrials.Veeva

Menu

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

A

asmaa salama ibrahim

Status

Completed

Conditions

Colorectal Carcinoma
Signet Ring Adenocarcinoma of the Colon
Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This original research investigates the critical issue of gastrointestinal (GI) second primary malignancies (SPMs) in patients with signet ring cell carcinoma (SRCC), a rare and aggressive subtype of colorectal cancer. Utilizing the Surveillance, Epidemiology, and End Results (SEER) database, the investigators assessed the risk of GI SPMs, particularly within 2-11 months post-SRCC diagnosis.

Enrollment

8,171 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with primary colorectal SRCC between 2000 and 2021
  • Latency exclusion period of two months

Exclusion criteria

  • patients with unknown age data

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems